CARBIDOPA AND LEVODOPA Detail

Drug Name(s):
CARBIDOPA AND LEVODOPA

FDA Application No.:
NDA 075091

Active Ingredient(s):
CARBIDOPA; LEVODOPA

Company:
MYLAN

Original Approval or Tentative Approval Date:
September 29, 1999

Products on Application NDA 075091:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
CARBIDOPA; LEVODOPA	50MG;200MG	TABLET, EXTENDED RELEASE; ORAL	Prescription	AB

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

January 2009

CARBIDOPA AND LEVODOPA Detail

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed

Welcome

Diseases & Conditions

Navigation

Resources

Medical Dictionary

Drug Information

Events

Who's online

Job search